DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Norfenfluramine
Norfenfluramine
Investigating Interactions Between Phentermine, Dexfenfluramine, and 5-HT2C Agonists, on Food Intake in the Rat
(19) United States (12) Patent Application Publication (10) Pub
Pharmacology and Toxicology of Amphetamine and Related Designer Drugs
Mediator°: Norfenfluramine at the Heart of the Trial
Differentially Affect Monoamine Transporters and Abuse Liability
212102Orig1s000
Neural Control of Dieting Counting Species Names
The Substituted Amphetamines 3,4
High-Performance Liquid Chromatographic Analysis of Drugs of Abuse in Biologic Samples
Serotonin Receptors and Drugs Affecting Serotonergic Neurotransmission R ICHARD A
Effect of Dexfenfluramine on Gastric Emptying of a Mixed Solid-Liquid
Psychoactive Drugs—From Chemical Structure to Oxidative Stress Related to Dopaminergic Neurotransmission
212102Orig1s000
Discovering the Molecular and Cellular Mechanisms Underlying Fenfluramine-Induced Cardiopulmonary Side Effects
Substance: Norfenfluramine Based on the Current
The Fenfluramine Metabolite ()-Norfenfluramine Is Vasoactive
Arrêté De L'exécutif Établissant La Liste De Substances Et Moyens Visés Par
(12) United States Patent (10) Patent No.: US 7,795,436 B2 Chen Et Al
Top View
Aripiprazole, a Novel Atypical Antipsychotic Drug with a Unique and Robust Pharmacology
A Summary of Antiseizure Medications Available in the United States: 2020 Update
3,4-N-Methlenedioxymethamphetamine-Induced Hypophagia Is Maintained in 5-HT1B Receptor Knockout Mice, but Suppressed by the 5-HT2C Receptor Antagonist RS102221
Discriminative Stimulus Effects of 3,4-Methylenedioxypyrovalerone and 4-Methylmethcathinone
Serotonergic-Dopaminergic Mediation of -Ties Yof 3 4-Methylenedioxymethamphetamine Mid Nistre (MDMA, "Ecstasy") Ail T of )F a MARTIND
Dissociates in Vivo Serotonin Release from Long-Term Serotonin Depletion in Rat Brain Michael H
Arrêté De L'exécutif De La Communauté Française Modifiant Et Remplaçant L
3,4-Methylenedioxyamphetamine (MDA) Analogues Exhibit Differential Effects on Synaptosomal Release of 3H-Dopamine and 3H-5-Hydroxytryptamine
(+)-Norfenfluramine- Induced Arterial Contraction and Blood Pressure Increase in DOCA-Salt Hypertension
(MDMA) by (± )-MDMA Neurotoxicity: Protection by Fluoxetine
The Chickasaw Nation GAMING COMMISSIONER’S REGULATIONS
FINTEPLA® (Fenfluramine)
Assessment Report
MDMA (Ecstasy) Inhibition of MAO Type a and Type B: Comparisons with Fenfluramine and Fluoxetine (Prozac) Efthimia T
5-HT2B Receptor-Mediated Cardiac Valvulopathy
Fenfluramine-Like Cardiovascular Side- Effects of Benfluorex
212102Orig1s000
Emerging Selectivity of Serotonin Receptor Subtype–Targeted Drugs
New Tests and Test Updates